Cell Source Inc.

Cell Source Inc.
Stock Exchange Other OTC
EPS
$0.12
Market Cap
$21.33 M
Shares Outstanding
26.08 M
Public Float
17.89 M

Profile

Address
57 West 57th Street
New York New York 10019
United States
Employees -
Website http://www.cell-source.com
Updated 07/08/2019
Cell Source, Inc. is a biotechnology company, which engages in the development of cell therapy treatments. It operates through Veto-Cell technology, which represents immune system management. The company was founded on June 6, 2012 and is headquartered in New York, NY.

Financials

View All

Itamar Shimrat
CEO, CFO, Director & Principal Accounting Officer
Ben Friedman
Director